Damora Therapeutics, Inc. Share Price
NASDAQ: DMRA | Micro CapDamora Therapeutics, Inc. Stock Performance
Damora Therapeutics, Inc. Share Price Today
As of 13 November 2026, Damora Therapeutics, Inc.'s share price is $22.04. The stock opened at $22.01, compared to its previous close of $23.25. During today's trading session, Damora Therapeutics, Inc.'s share price traded between $21.88 and $22.83, with an average price of $22.35. Over the past 52 weeks, the stock has recorded a high of $34.87 and a low of $16.59. In terms of performance, Damora Therapeutics, Inc.'s share price has declined by 11.59% over the last six months and is down 14.94% on a year-on-year basis.
Damora Therapeutics, Inc. Share Price Chart
Damora Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
About Damora Therapeutics, Inc.
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
Damora Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $21.84 | $21.96 | +2.28% |
Oct 2026 | $20.77 | $21.47 | +0.37% |
Sep 2026 | $28.00 | $21.39 | -30.05% |
Aug 2026 | $29.41 | $30.58 | +5.50% |
Jul 2026 | $26.34 | $28.98 | +11.61% |
Jun 2026 | $25.83 | $25.97 | +4.17% |
May 2026 | $26.09 | $24.93 | -2.98% |
Apr 2026 | $26.48 | $25.70 | -0.83% |
Mar 2026 | $27.93 | $25.91 | N/A |